Separate Pain From Poisoning

Drug addiction is not only heroin, cocaine or other illegal drugs, but also other prisons. You may also be addicted to prescribing narcotic analgesics, also known as opioids. This is a major crisis in which 500000 people in most countries die from opioids. Tim Peara is the financial director and general manager of Bridge Therapeutics. He has the ability to provide safer substitute materials for chronic pain to help cope with and contain the current Opioid crisis.

“BizTalk with Massimiliano Sulpizi” is an innovative arena where you can put forward entrepreneurial ideas. Design and run in EquityMatch. Work together to find opportunities for the community to raise funds for start-ups. The purpose of this plan is to provide opportunities for all entrepreneurs to find seed investment for their startups and share their entrepreneurial details with EquityMatch entrepreneurs. Through video conference.

Bridge Therapeutics has been studying a drug called buprenorphine, which is safe and effective for pain and poisoning. This greatly reduces the time cost and risk of FDA approval. Propofol is as strong as fentanyl, and fentanyl is the strongest opioid among painkillers. Fentanyl is about 35 or 30 times stronger than morphine, and the risk of overdose is about 50 times higher than morphine. Propofol is similar to fentanyl, but there is no risk of overdose. Because n-prenorphine is universal, in order to protect the product, barriers to entry are needed. This can be achieved in a variety of ways, including a delivery system called Zydis, market exclusivity, proprietary products, and enhancements. Bridge Therapeutics has no patent for these delivery systems, but they are well-known, commonly used and important. Therefore, this has become the first and basis for building economic barriers around their work. For the achievements, Bridge Therapeutics designed the delivery method two years ago and submitted the first document named Research New Drug(IND) to FDA last year. Therefore, Bridge Therapeutics is committed to separating pain and poisoning and solving the drug field of opium crisis.

Stock matching. Founded by Massimiliano Sulpizi, the company is a fanatical entrepreneur, venture capitalist, commercial banker and executive. As the founder and management partner of HSMI Corporate Advisory, he has provided clients with more than 100 million euros of advice on total transactions and more than 50 million euros of fund raising in the fields of infrastructure, fashion, real estate and technology. He is currently a consultant and member of the board of directors of EU/Hong Kong medical and technology start-ups and growth companies.

Stock matching. Help the founders find the ideal source of venture capital. This is a platform for encouraging venture capital. It can also create profiles containing information and disseminate innovative ideas through video streams, thus providing opportunities to find the right investors. This is to provide entrepreneurs who want seed stage financing with services up to the pre IPO stage. There is no need to re create company introductions at each stage of the financing process.